PPTDF (PeptiDream) Cyclically Adjusted Revenue per Share: $0.92 (As of Mar. 2026)


PPTDF PeptiDream Inc PPTDF
72 GF Score
Price $6.00
GF Value $10.24
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is PeptiDream Cyclically Adjusted Revenue per Share?

PeptiDream PPTDF 72 Cyclically Adjusted Revenue per Share is $0.92 as of Mar. 2026. GuruFocus rates PPTDF with a GF Score™ of 72/100 and a GF Value™ of $10.24 (Possible Value Trap). The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

PeptiDream's adjusted revenue per share for the three months ended in Mar. 2026 was $0.233. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is $0.92 for the trailing ten years ended in Mar. 2026.

During the past 12 months, PeptiDream's average Cyclically Adjusted Revenue Growth Rate was 9.40% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 29.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of PeptiDream was 29.10% per year. The lowest was 29.10% per year. And the median was 29.10% per year.

As of today (2026-07-04), PeptiDream's current stock price is $6.00. PeptiDream's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was $0.92. PeptiDream's Cyclically Adjusted PS Ratio of today is 6.52.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of PeptiDream was 34.94. The lowest was 6.58. And the median was 16.89.


PeptiDream  (OTCPK:PPTDF) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

PeptiDream's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=6.00/0.92
=6.52

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of PeptiDream was 34.94. The lowest was 6.58. And the median was 16.89.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


PeptiDream Cyclically Adjusted Revenue per Share Related Terms


PeptiDream Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for PeptiDream's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PeptiDream Cyclically Adjusted Revenue per Share Chart

PeptiDream Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.38 0.50 0.85 1.05

PeptiDream Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.06 1.05 0.95 1.05 0.92

PPTDF vs VRTX, REGN, ALNY: Cyclically Adjusted Revenue per Share Comparison

For the Biotechnology subindustry, PeptiDream's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PeptiDream Cyclically Adjusted PS Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PeptiDream's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where PeptiDream's Cyclically Adjusted PS Ratio falls into.


PPTDF
72GF Score
PeptiDream Inc PPTDF
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PeptiDream Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, PeptiDream's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.233/112.7000*112.7000
=0.233

Current CPI (Mar. 2026) = 112.7000.

PeptiDream Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 0.120 98.100 0.138
201609 0.060 98.000 0.069
201612 0.024 98.400 0.027
201703 0.017 98.100 0.020
201706 0.240 98.500 0.275
201709 0.013 98.800 0.015
201712 0.055 99.400 0.062
201803 0.017 99.200 0.019
201806 0.392 99.200 0.445
201809 0.037 99.900 0.042
201812 0.101 99.700 0.114
201903 0.062 99.700 0.070
201906 0.317 99.800 0.358
201909 0.029 100.100 0.033
201912 0.047 100.500 0.053
202003 0.029 100.300 0.033
202006 0.201 99.900 0.227
202009 0.053 99.900 0.060
202012 0.582 99.300 0.661
202103 0.107 99.900 0.121
202106 0.322 99.500 0.365
202109 0.343 100.100 0.386
202112 0.108 100.100 0.122
202203 0.027 101.100 0.030
202206 0.265 101.800 0.293
202209 0.332 103.100 0.363
202212 0.890 104.100 0.964
202303 0.286 104.400 0.309
202306 0.243 105.200 0.260
202309 0.684 106.200 0.726
202312 0.330 106.800 0.348
202403 0.218 107.200 0.229
202406 1.557 108.200 1.622
202409 0.295 108.900 0.305
202412 0.254 110.700 0.259
202503 0.219 111.100 0.222
202506 0.231 111.700 0.233
202509 0.226 112.000 0.227
202512 0.281 113.000 0.280
202603 0.233 112.700 0.233

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of $0.92 mean?
PeptiDream (PPTDF) has a Cyclically Adjusted Revenue per Share of $0.92 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on PeptiDream and its competitors.
Is PeptiDream's Cyclically Adjusted Revenue per Share too high?
PeptiDream's current Cyclically Adjusted Revenue per Share is $0.92. Overall, PeptiDream has a GF Score™ of 72/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does PeptiDream's Cyclically Adjusted Revenue per Share compare to VRTX and REGN?
PeptiDream's Cyclically Adjusted Revenue per Share of $0.92 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Biotechnology company?
A good Cyclically Adjusted Revenue per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on PeptiDream and its competitors. PeptiDream's current Cyclically Adjusted Revenue per Share is $0.92. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PeptiDream stock overvalued right now?
Based on GuruFocus' analysis, PeptiDream (PPTDF) is currently considered Possible Value Trap. The stock's GF Value™ is $10.24, compared to a current price of $6.00 — trading 41.4% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is $0.92. PeptiDream's overall GF Score™ is 72/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For PeptiDream (PPTDF), the current Cyclically Adjusted Revenue per Share is $0.92 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PeptiDream (PPTDF) Overvalued in 2026?

Based on GuruFocus' analysis, PeptiDream stock appears to be undervalued. The current stock price of $6.00 is trading 41.4% below its estimated GF Value™ of $10.24. GuruFocus considers PeptiDream to be Possible Value Trap.

Key valuation signals for PPTDF:

  • Cyclically Adjusted Revenue per Share: $0.92
  • GF Value™: $10.24 vs. price of $6.00 (41.4% below fair value)
  • GF Score™: 72/100 with 4 warning signs

No single metric tells the full story. See the PPTDF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


PeptiDream Business Description

Other Exchanges 4587:Japan
Address 3-25-23 Tonomachi, Kawasaki-ku, Kanagawa Prefecture, Kawasaki, JPN, 210-0821
PeptiDream Inc is engaged in the drug discovery and development business. The group utilizes PDPS, its proprietary drug discovery and development platform system, for drug discovery and development, and it conducts radiopharmaceutical business through a wholly owned subsidiary and is involved in the research, development, and manufacturing of pharmaceuticals, etc. Its reportable segments are Drug discovery and development business and Radiopharmaceutical business.
72GF Score

Get the complete analysis for PPTDF

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$6.00
Price
$10.24
GF Value